The project aims to investigate markers of neural activity and connectivity, neurochemistry,
hypothalamic-pituitary-adrenal (HPA) axis activity, inflammation and neuronal plasticity
underlying treatment response and remission after ECT. These measures will be assessed in
depressive patients prior, during and after ECT and also after 6 months. Furthermore, we will
investigate a control group of depressive patients treated with antidepressants.